Landos Biopharma, Inc.
Landos Biopharma, Inc. (LABP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LABP · as of Jun 9, 2026
Key Statistics
Explore Landos Biopharma, Inc. Data
labp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 28.6%
Competitors & Peers
labp competitorsLABP
ACHL
BLI
HTBX
IGMS
JBIOStock Performance
Full HistoryAbout Landos Biopharma, Inc.
Landos Biopharma, Inc. is a biopharmaceutical firm operating in the clinical stage, focused on the discovery and development of innovative oral therapies aimed at treating a range of autoimmune disord…
what is landos biopharma, inc. · labp stock overview · landos biopharma, inc. company profile · who is landos biopharma, inc. ceo · labp NASDAQ · landos biopharma, inc. headquarters · landos biopharma, inc. business segments
About Stock Overview & Key Data
Landos Biopharma, Inc. (LABP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 4, 2021. As of the latest trading session, LABP stock price is $22.93, with a market capitalization of $71.7M. The stock has returned +562.72% over the past 12 months and +430.79% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Landos Biopharma, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2023, Landos Biopharma, Inc. reported revenue of — and net income of -$21.9M. For detailed data — including Landos Biopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Landos Biopharma, Inc. (LABP) stock price is $22.93. The stock is traded on NASDAQ under the ticker symbol LABP. The 52-week range is $3.15 – $22.94.